CORAL GABLES, Fla.--(BUSINESS WIRE)--Stiefel Laboratories, Inc., the world's largest independent pharmaceutical company specializing in dermatology, today announced that the U.S. Food and Drug ...
BUENA, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's ...
DUBLIN, March 9, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that it has launched a generic version of Fougera's Temovate® ...
Actavis Approved for Generic Subutex Actavis announced the launch of Clobetasol Propionate Cream 0.05%, the generic version of Fougera's Temovate. Actavis announced the launch of Clobetasol Propionate ...
To date, the Company has not received reports of adverse events related to this recall. Taro Pharmaceuticals has issued a voluntary recall of 1 lot of Clobetasol Propionate Ointment USP, 0.05%, 60g ...
Taro Pharmaceuticals U.S.A., Inc. (“Taro” or the “Company”) is voluntarily recalling one (1) lot of Clobetasol Propionate Ointment USP, 0.05% packaged in 60 g tubes, to the consumer level. This recall ...
Clobetasol is a generic prescription drug used to treat itchiness and inflammation from skin conditions, including plaque psoriasis. Clobetasol’s cost may depend on factors such as its form and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results